InsidersTradesSigma
CStone Pharmaceuticals - B Stock: price and insider trades · Hong Kong · HKEX
Track the CStone Pharmaceuticals - B share price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. Operating in the Health Care sector, CStone Pharmaceuticals - B has published 21 insider filings. Market capitalisation: €8.6bn. The latest transaction was filed on 7 July 2026 (Other). Among the most active insiders: Yang Jianxin. Every trade is accessible without an account.
21
Insider Decl.
0
Thresholds
€1m
14 ops.
Buy Volume
·
0 ops.
Sell Volume
24Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,355 of 26,134 companies
18.3
score / 100
Value23
Quality13
FCF yld-3.8%
Earn yld-5.1%
EV/EBITDA·
ROE-89%
Gross mgn19%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 July 2026
Declarations21 total
63,000 sharesShareXHKGHKEX:DA20260707E00463
331,000 shares@ €0.51840.018% mcap30.2% of flowShareXHKGHKEX:DA20260701E00109
Ideal exit: 27 Mar 2027 (T+270)
448,875 sharesShareXHKGHKEX:DA20260701E00108
11,270,000 sharesShareXHKGHKEX:DA20260625E00306
Ideal exit: 20 Mar 2027 (T+270)
56,500 shares@ €0.51370.0004% mcap7.3% of flowShareXHKGHKEX:DA20260615E00264
Ideal exit: 9 Mar 2027 (T+270)
200,000 shares@ €0.50380.0014% mcap25.4% of flowShareXHKGHKEX:DA20260612E00338
Ideal exit: 9 Mar 2027 (T+270)
400,000 shares@ €0.49570.0027% mcap100.0% of flowShareXHKGHKEX:DA20260610E00351
Ideal exit: 5 Mar 2027 (T+270)
145,000 shares@ €0.47120.0009% mcap17.2% of flowShareXHKGHKEX:DA20260610E00353
Ideal exit: 7 Mar 2027 (T+270)
200,000 shares@ €0.47060.0013% mcap47.4% of flowShareXHKGHKEX:DA20260609E00345
Ideal exit: 6 Mar 2027 (T+270)
200,000 shares@ €0.52270.0014% mcap52.6% of flowShareXHKGHKEX:DA20260605E00376
Ideal exit: 2 Mar 2027 (T+270)
105,000 shares@ €0.5361ShareXHKGHKEX:DA20260603E00307
Ideal exit: 28 Feb 2027 (T+270)
21 of 21 declarations
About CStone Pharmaceuticals - B
CStone Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for cancer. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.